CDPX2 must be differentiated from other short limb deformities, including skeletal dysplasia, other genetic or metabolic diseases, and vitamin K metabolic diseases (e.g., fetal exposure to the anticoagulant warfarin, or vitamin K epoxide reductase deficiency). This evidence concerns the gene EBP and Other metabolic disease.